{
    "title": "GSK surpasses profit expectations on pain medication stockpiling",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8269151/GSK-profit-beats-Shingrix-demand-pain-meds-pandemic.html",
    "date": "2020-04-29",
    "keywords": [
        "gsk",
        "vaccine",
        "coronavirus",
        "walmsley",
        "year",
        "pushkala",
        "aripaka",
        "burger",
        "profit",
        "demand",
        "company",
        "business",
        "hiv",
        "growth",
        "manufacturing",
        "pandemic",
        "shingrix",
        "pence",
        "blockbuster",
        "pain",
        "respiratory",
        "maker",
        "advil",
        "panadol",
        "wednesday",
        "spread",
        "lead",
        "stockpiling",
        "overthecounter",
        "boost",
        "consumption",
        "consumer",
        "china",
        "outbreak",
        "precrisis",
        "situation",
        "country",
        "executive",
        "emma",
        "pointing",
        "supply",
        "chain",
        "ability",
        "healthcare",
        "safety",
        "research",
        "covid19",
        "time",
        "deal",
        "sanofi",
        "push",
        "immunisation",
        "half",
        "quarter",
        "driver",
        "point",
        "capacity",
        "slowing",
        "vaccination",
        "moment",
        "pressure",
        "resurgence",
        "relevance",
        "uncertainty",
        "impact",
        "fall",
        "prediction",
        "drop",
        "firstquarter",
        "share",
        "beat",
        "expectation",
        "consensus",
        "httpswwwgskcomengbinvestorsanalystconsensusanalystconsensus",
        "ankur",
        "banerjee",
        "bengaluru",
        "frankfurt",
        "editing",
        "kurane",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}